A PHASE-I/II STUDY OF IMC-A12 IN CHILDREN WITH RELAPSED/ REFACTORY SOLID TUMORS"

IMC-A12 在复发/难治性实体瘤儿童中的 I/II 期研究"

• 批准号: 7958528
• 负责人: Charles T Roberts
• 金额: $ 3.45万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-04 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7958528
• 关键词: Antibody Therapy; Child; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Insulin-Like-Growth Factor I Receptor; Patients; Phase; Primates; Relapse; Research; Research Personnel; Resources; Solid Neoplasm; Source; United States National Institutes of Health; receptor

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project will determine IGF-I receptor protein levels in PBMC's from patients before and after anti-IGF-I receptor protein levels in PBMC's from patients before and after anti-IGF-IR antibody therapy.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该项目将测定抗 IGF-IR 抗体治疗前后患者 PBMC 中抗 IGF-I 受体蛋白水平。